Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Hollywood Wants To Use AI Replicas Of Actors, Major US Banks Deliver Q2 Earnings, Artificial Sweetener Aspartame Classified As 'Possible Carcinogen:' Today's Top Stories
July 14, 2023
Tickers
ATVI
BLK
C
ERIC
Tags
ROIV
JPM
Market News
From
Benzinga
Republican Presidential Candidate Vivek Ramaswamy Founded Roivant In Discussions With Roche For $7B Stomach Disease(s) Drug Deal
July 14, 2023
Tickers
PFE
RHHBF
RHHBY
RHHVF
Tags
Market News
M&A
RHHBY
From
Benzinga
Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion
July 13, 2023
Tickers
HALO
RHHBF
RHHBY
RHHVF
Tags
RHHBY
Market News
News
From
Benzinga
Monkeypox Vaccine: Blue Water Biotech Touts Encouraging Preclinical Data From Monkeypox Vaccine Candidate
June 28, 2023
Tickers
BWV
RHHBY
Tags
Market News
General
BWV
From
Benzinga
Roche's Bispecific Antibody With Fixed-Duration Treatment Scores FDA Approval For Type Of Lymphoma
June 16, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
Briefs
Benzinga
From
Benzinga
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
June 14, 2023
Tickers
EYPT
REGN
RHHBY
Tags
Trading Ideas
Health Care
News
From
Benzinga
New Data Show Roche's Self-Administered Blood Disorder Candidate Achieves Disease Control
June 09, 2023
Tickers
AZN
RHHBF
RHHBY
RHHVF
Tags
Health Care
News
Market News
From
Benzinga
AI: An Endless Opportunity or Existential Threat?
June 04, 2023
Tickers
AAPL
GOOGL
ICAD
IRBT
Tags
TTD
MSFT
Market News
From
InvestorPlace
Why Shares of Zentalis Pharmaceuticals Dropped This Week
June 02, 2023
Tickers
RHHBY
ZNTL
Tags
RHHBY
ZNTL
Market News
From
Motley Fool
Why Shares of Rain Oncology Are Plummeting Today
May 22, 2023
Tickers
RAIN
RHHBY
Tags
RHHBY
RAIN
Market News
From
Motley Fool
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
May 17, 2023
Tickers
ABBV
AZN
BCS
CS
Tags
Market News
VZ
TEVA
From
Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
May 17, 2023
Tickers
MKGAF
RHHBF
RHHBY
RHHVF
Tags
Benzinga
Biotech
Briefs
From
Benzinga
AI Meets Biotech: Transforming the Drug Development Process
May 16, 2023
Tickers
AZN
BAYRY
RHHBY
SNY
Tags
RHHBY
AZN
Market News
From
InvestorPlace
3 Stocks That Are Reshaping the Future
May 16, 2023
Tickers
MSFT
RHHBY
ZBH
Tags
ZBH
Market News
MSFT
From
InvestorPlace
3 Personalized Medicine Stocks to Buy for Long-Time Returns
May 15, 2023
Tickers
ADPT
EXAS
GSK
ME
Tags
Stocks to Buy
ADPT
EXAS
From
InvestorPlace
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
May 04, 2023
Tickers
RHHBY
SABS
Tags
Penny Stocks
Health Care
Top Stories
From
Benzinga
Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish
April 28, 2023
Tickers
RHHBY
TPST
Tags
Price Target
Expert Ideas
TPST
From
Benzinga
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
April 26, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHBY
RHHBF
From
Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
April 26, 2023
Tickers
REGN
RHHBY
SABS
Tags
Biotech
Penny Stocks
Benzinga
From
Benzinga
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
Tickers
BGNE
BIIB
LLY
NVS
Tags
BIIB
VKTX
RHHBY
From
Motley Fool
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health
April 25, 2023
Tickers
ABT
DXCM
RHHBY
TECH
Tags
DXCM
General
RHHBY
From
Benzinga
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
April 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
Biotech
Benzinga
From
Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
April 13, 2023
Tickers
RHHBF
RHHBY
RHHVF
SABS
Tags
Biotech
Benzinga
RHHBF
From
Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
April 11, 2023
Tickers
ADAP
GSK
RHHBY
Tags
Recent Press Releases
GSK
ADAP
From
Motley Fool
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
March 30, 2023
Tickers
BMY
BOLT
RHHBY
Tags
Market News
General
RHHBY
From
Benzinga
Roche's Slow Growth Shouldn't Drive Investors Away
March 28, 2023
Tickers
RHHBY
Tags
RHHBY
Market News
Recent Press Releases
From
Motley Fool
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
March 22, 2023
Tickers
LLY
RHHBY
Tags
Health Care
LLY
Benzinga
From
Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
March 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
General
RHHVF
From
Benzinga
Is Roche a Buy Now?
March 20, 2023
Tickers
RHHBY
Tags
Recent Press Releases
Market News
RHHBY
From
Motley Fool
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
March 17, 2023
Tickers
RHHBY
SRPT
Tags
News
Health Care
RHHBY
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.